A role for m6A RNA methylation in heart failure development?

Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt

  • on behalf of EU-CardioRNA COST Action CA17129
This article refers to ‘Changes in m6A RNA methylation contribute to heart failure progression by modulating translation’ by T. Berulava et al., published in this issue on pages 54–66.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Heart Failure
Vol/bind22
Udgave nummer1
Sider (fra-til)67-69
Antal sider3
ISSN1388-9842
DOI
StatusUdgivet - 2020

Bibliografisk note

Funding Information:
Dr. Devaux is Chair of the EU-CardioRNA COST ACTION CA17129 (www.cardiorna.eu), supported by COST (European Cooperation in Science and Technology). Dr. Devaux is supported by the National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), the Ministry of Higher Education and Research of Luxembourg, and the Heart Foundation – Daniel Wagner. Dr Nossent is funded by a Lise Meitner grant (M2578-B30) of the Austrian Science Fund FWF. Conflict of interest: none declared.

Funding Information:
Dr. Devaux is Chair of the EU‐CardioRNA COST ACTION CA17129 ( www.cardiorna.eu ), supported by COST (European Cooperation in Science and Technology). Dr. Devaux is supported by the National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), the Ministry of Higher Education and Research of Luxembourg, and the Heart Foundation – Daniel Wagner. Dr Nossent is funded by a Lise Meitner grant (M2578‐B30) of the Austrian Science Fund FWF.

ID: 395075018